Dr David Candelaria, MD - Medicare Family Practice in Ashland, OR

Dr David Candelaria, MD is a medicare enrolled "Family Medicine" physician in Ashland, Oregon. He went to University Of Colorado School Of Medicine, Denver and graduated in 1989 and has 35 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Asante Physician Partners, Lower Umpqua Hospital District and his current practice location is 280 Maple St, Ashland, Oregon. You can reach out to his office (for appointments etc.) via phone at (541) 201-4000.

Dr David Candelaria is licensed to practice in Oregon (license number MD17629) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1033112271.

Contact Information

Dr David Candelaria, MD
280 Maple St,
Ashland, OR 97520-1552
(541) 201-4000
Not Available



Physician's Profile

Full NameDr David Candelaria
GenderMale
SpecialityFamily Practice
Experience35 Years
Location280 Maple St, Ashland, Oregon
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr David Candelaria attended and graduated from University Of Colorado School Of Medicine, Denver in 1989
  NPI Data:
  • NPI Number: 1033112271
  • Provider Enumeration Date: 05/23/2005
  • Last Update Date: 09/03/2011
  Medicare PECOS Information:
  • PECOS PAC ID: 0547165292
  • Enrollment ID: I20031204001109

Medical Identifiers

Medical identifiers for Dr David Candelaria such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1033112271NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine MD17629 (Oregon)Primary
207Q00000XFamily Medicine 31332 (Colorado)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Lower Umpqua Hospital DistrictReedsport, ORHospital
Asante Ashland Community HospitalAshland, ORHospital

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr David Candelaria allows following entities to bill medicare on his behalf.
Entity NameJosephine County
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1295737336
PECOS PAC ID: 0941193957
Enrollment ID: O20040204000415

News Archive

Sarepta Therapeutics wins accelerated approval from FDA for Duchenne muscular dystrophy drug

The U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD).

Copper-bottomed guarantee for safe shellfish in restaurants

Putting brass where your money is could be a guarantee of safety according to researchers looking at the dangers of eating raw fish and shellfish in seafood restaurants, scientists heard today (Wednesday 10 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.

Researchers develop hybrid nanomaterial for destruction of cancer cells

Most tumors contain regions of low oxygen concentration where cancer therapies based on the action of reactive oxygen species are ineffective.

Pitt scientists identify two new classes of RNAs closely associated with cancer biomarker

Researchers at the University of Pittsburgh School of Medicine have identified two new classes of RNAs that are closely associated with a protein known to be a prognostic biomarker for breast cancer and could play a role in progression of prostate cancer.

Protease inhibitor found to aid diabetic retinopathy treatment

Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, announced today that they have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440, developed by ActiveSite Pharmaceuticals, may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes.

Read more Medical News

› Verified 1 days ago

Entity NameLower Umpqua Hospital District
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1003874819
PECOS PAC ID: 6800703562
Enrollment ID: O20040212000228

News Archive

Sarepta Therapeutics wins accelerated approval from FDA for Duchenne muscular dystrophy drug

The U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD).

Copper-bottomed guarantee for safe shellfish in restaurants

Putting brass where your money is could be a guarantee of safety according to researchers looking at the dangers of eating raw fish and shellfish in seafood restaurants, scientists heard today (Wednesday 10 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.

Researchers develop hybrid nanomaterial for destruction of cancer cells

Most tumors contain regions of low oxygen concentration where cancer therapies based on the action of reactive oxygen species are ineffective.

Pitt scientists identify two new classes of RNAs closely associated with cancer biomarker

Researchers at the University of Pittsburgh School of Medicine have identified two new classes of RNAs that are closely associated with a protein known to be a prognostic biomarker for breast cancer and could play a role in progression of prostate cancer.

Protease inhibitor found to aid diabetic retinopathy treatment

Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, announced today that they have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440, developed by ActiveSite Pharmaceuticals, may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes.

Read more Medical News

› Verified 1 days ago

Entity NameAsante Physician Partners
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1922381326
PECOS PAC ID: 8325206246
Enrollment ID: O20120223000671

News Archive

Sarepta Therapeutics wins accelerated approval from FDA for Duchenne muscular dystrophy drug

The U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD).

Copper-bottomed guarantee for safe shellfish in restaurants

Putting brass where your money is could be a guarantee of safety according to researchers looking at the dangers of eating raw fish and shellfish in seafood restaurants, scientists heard today (Wednesday 10 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.

Researchers develop hybrid nanomaterial for destruction of cancer cells

Most tumors contain regions of low oxygen concentration where cancer therapies based on the action of reactive oxygen species are ineffective.

Pitt scientists identify two new classes of RNAs closely associated with cancer biomarker

Researchers at the University of Pittsburgh School of Medicine have identified two new classes of RNAs that are closely associated with a protein known to be a prognostic biomarker for breast cancer and could play a role in progression of prostate cancer.

Protease inhibitor found to aid diabetic retinopathy treatment

Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, announced today that they have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440, developed by ActiveSite Pharmaceuticals, may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr David Candelaria is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr David Candelaria, MD
Po Box 490,
Grants Pass, OR 97528-0041

Ph: (541) 955-4655
Dr David Candelaria, MD
280 Maple St,
Ashland, OR 97520-1552

Ph: (541) 201-4000

News Archive

Sarepta Therapeutics wins accelerated approval from FDA for Duchenne muscular dystrophy drug

The U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD).

Copper-bottomed guarantee for safe shellfish in restaurants

Putting brass where your money is could be a guarantee of safety according to researchers looking at the dangers of eating raw fish and shellfish in seafood restaurants, scientists heard today (Wednesday 10 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.

Researchers develop hybrid nanomaterial for destruction of cancer cells

Most tumors contain regions of low oxygen concentration where cancer therapies based on the action of reactive oxygen species are ineffective.

Pitt scientists identify two new classes of RNAs closely associated with cancer biomarker

Researchers at the University of Pittsburgh School of Medicine have identified two new classes of RNAs that are closely associated with a protein known to be a prognostic biomarker for breast cancer and could play a role in progression of prostate cancer.

Protease inhibitor found to aid diabetic retinopathy treatment

Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, announced today that they have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440, developed by ActiveSite Pharmaceuticals, may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes.

Read more News

› Verified 1 days ago


Family Medicine Doctors in Ashland, OR

Dr. Jerome Stanford Nitzberg, M.D.
Family Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 273 Granite St, Ashland, OR 97520
Phone: 541-488-2130    
Anne Taylor, NP
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 935 Siskiyou Blvd, Ashland, OR 97520
Phone: 541-482-2716    Fax: 541-488-5461
Steven Wells, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 534 Washington St, Ashland, OR 97520
Phone: 541-203-0737    
Dr. Jenna Elizabeth Diggs, MD
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 560 Catalina Dr, Ashland, OR 97520
Phone: 541-201-4800    
Dr. Rivka Ann Sanders, MD
Family Medicine
Medicare: Medicare Enrolled
Practice Location: 540 Catalina Dr, Ashland, OR 97520
Phone: 541-482-0061    Fax: 888-869-7645
Daniel James Sengenberger, D.O.
Family Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 850 Siskiyou Blvd Ste 7, Ashland, OR 97520
Phone: 541-482-2920    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.